Inglés

investigational product and blinded study salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 formularios  
investigational product
Descripción

investigational product

Alias
UMLS CUI-1
C0304229
Start Date
Descripción

Day Month Year

Tipo de datos

date

Alias
UMLS CUI [1]
C0808070
Stop Date
Descripción

Day Month Year

Tipo de datos

date

Alias
UMLS CUI [1]
C0806020
INVESTIGATIONAL PRODUCT COMPLIANCE
Descripción

INVESTIGATIONAL PRODUCT COMPLIANCE

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
Date Investigational Product Dispensed
Descripción

date investigational product dispensed

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0808070
Dose Counter Stop
Descripción

Note dose for each Double-Blind Diskus 1, 2, 3 separately.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0678766
UMLS CUI [1,2]
C0806020
INVESTIGATIONAL PRODUCT COMPLIANCE
Descripción

INVESTIGATIONAL PRODUCT COMPLIANCE

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
Date Investigational Product Dispensed
Descripción

date investigational product dispensed

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0808070
Dose Counter Stop
Descripción

Note dose for each Double-Blind Diskus 1, 2, 3 separately.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0678766
UMLS CUI [1,2]
C0806020
INVESTIGATIONAL PRODUCT COMPLIANCE
Descripción

INVESTIGATIONAL PRODUCT COMPLIANCE

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
Date Investigational Product Dispensed
Descripción

date investigational product dispensed

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0808070
Dose Counter Stop
Descripción

Note dose for each Double-Blind Diskus 1, 2, 3 separately.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0678766
UMLS CUI [1,2]
C0806020
INVESTIGATIONAL PRODUCT COMPLIANCE
Descripción

INVESTIGATIONAL PRODUCT COMPLIANCE

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
Date Investigational Product Dispensed
Descripción

date investigational product dispensed

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0808070
Dose Counter Stop
Descripción

Note dose for each Double-Blind Diskus 1, 2, 3 separately.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0678766
UMLS CUI [1,2]
C0806020
STATUS OF TREATMENT BLIND
Descripción

STATUS OF TREATMENT BLIND

Alias
UMLS CUI-1
C0749659
UMLS CUI-2
C2347038
Was the treatment blind broken during the study?
Descripción

treatment status of blinded clinical study

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0749659
UMLS CUI [1,2]
C2347038
Date blind broken
Descripción

if treatment blind broken during the study

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2347038
UMLS CUI [1,2]
C0011008
Reason blind broken
Descripción

if treatment blind broken during the study if "other reason", specify that

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C2347038
Volver a la parte superior de la página

Similar models

investigational product and blinded study salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
investigational product
C0304229 (UMLS CUI-1)
start date
Item
Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
Stop Date
date
C0806020 (UMLS CUI [1])
Item Group
INVESTIGATIONAL PRODUCT COMPLIANCE
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
date investigational product dispensed
Item
Date Investigational Product Dispensed
date
C0013230 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
product dose at end of treatment
Item
Dose Counter Stop
integer
C0678766 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
INVESTIGATIONAL PRODUCT COMPLIANCE
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
date investigational product dispensed
Item
Date Investigational Product Dispensed
date
C0013230 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
product dose at end of treatment
Item
Dose Counter Stop
integer
C0678766 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
INVESTIGATIONAL PRODUCT COMPLIANCE
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
date investigational product dispensed
Item
Date Investigational Product Dispensed
date
C0013230 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
product dose at end of treatment
Item
Dose Counter Stop
integer
C0678766 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
INVESTIGATIONAL PRODUCT COMPLIANCE
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
date investigational product dispensed
Item
Date Investigational Product Dispensed
date
C0013230 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
product dose at end of treatment
Item
Dose Counter Stop
integer
C0678766 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
STATUS OF TREATMENT BLIND
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
Item
Was the treatment blind broken during the study?
text
C0749659 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
treatment status of blinded clinical study
Code List
Was the treatment blind broken during the study?
CL Item
Yes (Y)
CL Item
No (N)
date of blind broken in clinical study
Item
Date blind broken
date
C2347038 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Reason blind broken
text
C3897431 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
subject unblinding event record in blinded clinical study
Code List
Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other, specify (Z)
Volver a la parte superior de la página